Psyched Wellness AI Stock Analysis
Want to see TSE:PSYC full AI Analyst Report?
Psyched Wellness (PSYC) AI Stock Analysis
Psyched Wellness
(CNQX:PSYC)
Psyched Wellness scores near the bottom of the range, driven overwhelmingly by its financial condition. Despite strong percentage revenue growth, the company now sells below cost, loses ~$5.5M on under $1M of sales, and burns ~$4.1M of cash per year against just $1.3M of assets and ~$0.54M of equity — implying minimal runway and near-certain dilution. The debt-free structure is the only meaningful offset. Valuation offers no support with negative earnings and no dividend, and the absence of technical indicators alongside a sub-penny share price underscores the speculative, high-risk nature of the stock.
Psyched Wellness (PSYC) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 1.13M
- Dividend Yield
- ―
- Average Volume (3M)
- 3,166
- Price to Earnings (P/E)
- -0.3
- Beta (1Y)
- 0.13
- Revenue Growth
- 115.14%
- EPS Growth
- -5.84%
- Country
- Canada
- Employees
- 1,800
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Packaged Foods
Psyched Wellness Business Overview & Revenue Model
Company Description
Psyched Wellness Ltd. operates as a health supplements enterprise, specializing in the production and distribution of artisanal medicinal mushrooms and their associated consumer packaged goods. A prominent offering is their Amanita Muscaria Tincture,...
Psyched Wellness Financial Statement Overview
Summary
Financials are very weak across all three statements. Revenue grew sharply (~385% in the TTM to ~$0.78M), but gross profit turned negative (-$0.44M), meaning product is being sold below cost, and net losses widened to ~$5.5M — more than seven times revenue. The balance sheet is effectively debt-free, which is the lone genuine strength, but equity has collapsed from $7.4M to ~$0.54M in two years and total assets have shrunk to $1.3M. Operating and free cash flow burn of ~$4.1M annually against that asset base leaves only weeks of runway, making dilutive financing or restructuring highly likely.
Income Statement
9Very NegativeBalance Sheet
20Very NegativeCash Flow
8Very Negative| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 775.14K | 472.30K | 623.16K | 321.10K | 14.27K | 0 |
| Gross Profit | -444.19K | 189.79K | 241.89K | 155.71K | 7,542 | 0 |
| EBITDA | -6.00M | -5.08M | -4.52M | -3.32M | -4.29M | -65.31K |
| Net Income | -5.47M | -5.04M | -4.26M | -3.43M | -4.30M | -4.50M |
Balance Sheet | ||||||
| Total Assets | 1.30M | 3.75M | 7.89M | 7.34M | 3.31M | 6.38M |
| Cash, Cash Equivalents and Short-Term Investments | 182.51K | 2.25M | 6.36M | 6.13M | 2.57M | 5.53M |
| Total Debt | 288.13K | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 761.42K | 644.82K | 449.33K | 303.56K | 198.07K | 178.15K |
| Stockholders Equity | 539.26K | 3.10M | 7.44M | 7.03M | 3.11M | 6.20M |
Cash Flow | ||||||
| Free Cash Flow | -4.11M | -4.05M | -3.11M | -3.11M | -3.18M | -3.04M |
| Operating Cash Flow | -4.11M | -4.05M | -3.10M | -3.03M | -3.09M | -3.01M |
| Investing Cash Flow | 2,519 | 0 | -2,777 | -44.84K | 126.99K | -28.58K |
| Financing Cash Flow | 1.08M | 0 | 3.39M | 6.64M | 0 | 6.51M |
Psyched Wellness Peers Comparison
Overall Rating
TSE:JWEL65Neutral
TSE:HBFG43Neutral
TSE:PSYC39Underperform
TSE:CULT38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 65Neutral | CAD 1.89B | 27.35 | 14.01% | 2.06% | 12.14% | 12.33% | |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| 43Neutral | CAD 217.99M | -9.77 | -264.78% | ― | 39.45% | -642.08% | |
| 39Underperform | CAD 2.04M | -0.31 | -305.94% | ― | 115.14% | -5.84% | |
| 38Underperform | CAD 789.24K | -0.46 | -9999.00% | ― | 3288.96% | 50.66% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:PSYC | Psyched Wellness Ltd | 0.01 | -0.01 | -50.00% | |
| TSE:JWEL | Jamieson Wellness | 45.67 | 12.85 | 39.16% | |
| TSE:HBFG | Happy Belly Food Group Inc | 1.31 | -0.41 | -23.84% | |
| TSE:MOOO.X | Happy Supplements Inc. | 0.35 | -0.03 | -7.89% | |
| TSE:CULT | Cult Food Science Corp. | 0.32 | -0.18 | -36.00% |
Psyched Wellness Corporate Events
Psyched Wellness Secures Related-Party Term Loan to Fund AMA Brand Operations
PositivePsyched Wellness has secured a US$110,577 term loan from Gotham Green funds, which will be used to fund operating expenses and inventory purchases tied to its AMA-branded Amanita Muscaria products. The loan, bearing interest at SOFR plus 5% and matur...
Psyched Wellness Secures Insider-Backed Term Loan to Fund AMA Brand Growth
PositivePsyched Wellness has secured US$230,000 in term notes from Gotham Green Fund III entities to fund operating expenses and inventory purchases tied to its AMA-branded mushroom-derived wellness products. The notes bear interest at SOFR plus 5% and are s...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 04, 2026